These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7746005)

  • 1. [Guillain-Barré syndrome. Clinical suspicion of adverse reaction to a drug].
    Toll J; Llorens MJ; Borrell F; Paredes I
    Med Clin (Barc); 1993 Sep; 101(7):275. PubMed ID: 7746005
    [No Abstract]   [Full Text] [Related]  

  • 2. [Exogenous gangliosides and Guillain-Barré syndrome].
    Orden AO; Presas JL
    Medicina (B Aires); 1997; 57(3):385-6. PubMed ID: 9640778
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carbamazepine as a cause of Guillain-Barré syndrome?].
    Noring L
    Lakartidningen; 1985 May; 82(19):1778, 1780. PubMed ID: 3999884
    [No Abstract]   [Full Text] [Related]  

  • 4. Disorder resembling Guillain-Barré syndrome on initiation of statin therapy.
    Rajabally YA; Varakantam V; Abbott RJ
    Muscle Nerve; 2004 Nov; 30(5):663-6. PubMed ID: 15389662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guillain-Barre syndrome associated to treatment with gold salts].
    Bonaventura I; Martínez S; Martínez I; Aguilar M
    Rev Clin Esp; 1993 Nov; 193(7):405-6. PubMed ID: 7904766
    [No Abstract]   [Full Text] [Related]  

  • 6. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
    Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
    Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of Guillain-Barré syndrome postpartum.
    Cheng Q; Jiang GX; Fredrikson S; Link H; de Pedro-Cuesta J
    Epidemiology; 1998 Nov; 9(6):601-4. PubMed ID: 9799167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain Barré syndrome as a sequela of organophosphorus poisoning.
    Adlakha A; Philip PJ; Dhar KL
    J Assoc Physicians India; 1987 Sep; 35(9):665-6. PubMed ID: 3436940
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.
    Sharief MK; McLean B; Thompson EJ
    Ann Neurol; 1993 Jun; 33(6):591-6. PubMed ID: 8498839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome following zimeldine treatment.
    Fagius J; Osterman PO; Sidén A; Wiholm BE
    J Neurol Neurosurg Psychiatry; 1985 Jan; 48(1):65-9. PubMed ID: 3156214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative Guillain-Barré syndrome, arachnoiditis, and epidural analgesia.
    Rosenberg SK; Stacey BR
    Reg Anesth; 1996; 21(5):486-9. PubMed ID: 8896016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides and Guillain-Barré syndrome. Science supports the use of gangliosides.
    Massarotti M; Matano R
    BMJ; 1994 Mar; 308(6929):654. PubMed ID: 8074748
    [No Abstract]   [Full Text] [Related]  

  • 13. Guillain Barre syndrome as a sequelae of organophosphate poisoning.
    Wadia RS
    J Assoc Physicians India; 1990 Feb; 38(2):187. PubMed ID: 2380144
    [No Abstract]   [Full Text] [Related]  

  • 14. Guillain Barre syndrome as a sequela of organophosphorus poisoning.
    Mishra VN; Raman PG
    J Assoc Physicians India; 1988 May; 36(5):347. PubMed ID: 3182700
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
    Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
    Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
    Hagensee ME; Benyunes M; Miller JA; Spach DH
    Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guillain-Barré syndrome. Variation on the theme].
    Karlsen B; Vedeler C
    Tidsskr Nor Laegeforen; 1996 Jan; 116(2):242-5. PubMed ID: 8633333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy.
    Shin IS; Baer AN; Kwon HJ; Papadopoulos EJ; Siegel JN
    Arthritis Rheum; 2006 May; 54(5):1429-34. PubMed ID: 16645971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do corticosteroids influence the disease course or mortality of Guillain Barre syndrome?
    Mehndiratta MM
    J Assoc Physicians India; 1996 Jun; 44(6):431. PubMed ID: 9282570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.